Livent Co. (NYSE:LTHM – Get Rating) has received an average recommendation of “Hold” from the fourteen analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $29.53.
Several research analysts have commented on LTHM shares. Deutsche Bank Aktiengesellschaft raised their target price on shares of Livent from $26.00 to $27.00 in a report on Tuesday, October 4th. B. Riley raised their target price on shares of Livent from $30.00 to $32.00 and gave the stock a “neutral” rating in a report on Thursday, October 27th. Vertical Research upgraded shares of Livent from a “hold” rating to a “buy” rating and set a $30.00 target price for the company in a report on Wednesday. Piper Sandler decreased their target price on shares of Livent from $42.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, December 15th. Finally, Raymond James raised their target price on shares of Livent from $33.00 to $35.00 and gave the stock an “outperform” rating in a report on Thursday, October 13th.
Hedge Funds Weigh In On Livent
Several hedge funds and other institutional investors have recently added to or reduced their stakes in LTHM. US Bancorp DE raised its position in Livent by 46.5% during the first quarter. US Bancorp DE now owns 21,176 shares of the company’s stock valued at $552,000 after acquiring an additional 6,726 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its position in Livent by 27.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 20,285 shares of the company’s stock valued at $529,000 after acquiring an additional 4,359 shares in the last quarter. HighTower Advisors LLC raised its position in Livent by 18.1% during the first quarter. HighTower Advisors LLC now owns 39,483 shares of the company’s stock valued at $1,033,000 after acquiring an additional 6,044 shares in the last quarter. Private Advisor Group LLC raised its position in Livent by 3.4% during the first quarter. Private Advisor Group LLC now owns 26,235 shares of the company’s stock valued at $684,000 after acquiring an additional 856 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its position in shares of Livent by 7.5% in the first quarter. PNC Financial Services Group Inc. now owns 39,016 shares of the company’s stock valued at $1,017,000 after purchasing an additional 2,726 shares during the period. Institutional investors own 90.62% of the company’s stock.
Livent Stock Performance
NYSE:LTHM opened at $19.55 on Friday. Livent has a twelve month low of $18.26 and a twelve month high of $36.38. The company has a current ratio of 3.52, a quick ratio of 2.65 and a debt-to-equity ratio of 0.18. The company has a 50-day moving average of $25.63 and a 200-day moving average of $27.15. The firm has a market cap of $3.51 billion, a price-to-earnings ratio of 19.55 and a beta of 1.76.
Livent (NYSE:LTHM – Get Rating) last posted its quarterly earnings data on Tuesday, November 1st. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. Livent had a net margin of 27.67% and a return on equity of 20.00%. The company had revenue of $231.60 million during the quarter, compared to analyst estimates of $248.19 million. Analysts forecast that Livent will post 1.36 earnings per share for the current fiscal year.
Livent Company Profile
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Livent, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Livent wasn’t on the list.
While Livent currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
